- Neither RU-58841 nor pyrilutamide is an approved medicine anywhere; both are sold only as reference materials for laboratory research.
- The two analytical questions that matter are identity (is it the stated molecule?) and assay (how much of it is there?). They are separate tests.
- A sample report covers the sample tested. It is not a per-unit certificate unless the supplier says so and the batch numbers match.
- Labs that serve this market generally offer online report verification by ID; a report you cannot verify is just a picture.
- Storage conditions, batch labelling, shipping origin and legal framing are all checkable from a product page before you order.
- Judge a supplier on what you can verify, not on what they claim: a named lab, a checkable report ID, identity and assay results, a batch number on the label that matches the report.
- Read the wording. "Published sample report" and "every batch tested" are different promises; a supplier that blurs them is telling you something.
- Shipping origin and legal status decide whether the parcel reaches you and on what terms. For UK and EU buyers, a supplier inside the destination's customs area removes a whole category of risk.
Why is choosing a supplier harder in this category?
Because there is no regulator checking the product and no pharmacopoeia monograph to test against. RU-58841 was abandoned in development before any approval; pyrilutamide (KX-826) has a positive Phase 3 result but no marketing authorisation. Both circulate as research chemicals, which means the only quality system in play is whatever the supplier chooses to build and publish. "Best RU58841 vendor" lists online are mostly affiliate pages, and the ranking usually tracks commission rather than analytics. The useful alternative is a checklist you can apply to any supplier, including this one, in a few minutes. If you are new to the compounds, start with What is RU58841? and What is pyrilutamide?
1. Identity: does the report show it is the stated molecule?
The first thing a report should establish is that the material is RU-58841 or pyrilutamide and not a lookalike. Identity is normally confirmed by mass spectrometry (a molecular mass matching the expected value, 369.3 g/mol for RU-58841 and 482.4 g/mol for pyrilutamide) or by NMR, sometimes alongside HPLC retention time against a reference standard. A purity percentage on its own does not prove identity: HPLC can report a sample as 99% of one peak without telling you what that peak is. Look for the identity method named explicitly.
2. Purity or assay: how much of it is actually there?
The second number answers a different question: of what is in the vial, how much is the compound? For a powder this is usually expressed as purity (percentage by HPLC area or against a reference). For a solution it is an assay in mg/mL against the label. The distinction matters. A 5% solution should test close to 50 mg/mL; a result well under label suggests either under-filling or degradation, and a result far over label is also a flag, since it means the supplier does not control concentration. Published results in this market tend to land within a few percent of label; the point of reading them is to see that the supplier measured, not to hunt for a perfect number.
3. Is the laboratory named, and can the report be verified?
A report is only as good as the lab behind it and your ability to check it. Independent analytical labs that serve the research-chemical market generally publish each report with a unique task or report ID and run a public verification page where that ID can be entered to confirm the document is genuine. A report with the lab's name cropped out, no ID, or a lab that cannot be found is not evidence of anything. Also check who commissioned the test: a supplier-commissioned report is normal and acceptable, but it should be dated and should describe the sample in a way you can match to a product.
4. Batch ID: can you connect the report to the label?
This is the step most buyers skip and most sellers hope they will. A sample report describes the sample sent to the lab. Whether it describes the unit in your order depends on whether the supplier assigns batch numbers, prints them on the label, and publishes a report per batch. Read the supplier's own wording carefully. "Published sample report" means a named sample was tested and the report is public; it does not by itself claim that every batch sold was tested. "Every batch tested" is a stronger claim and should be backed by a matching set of batch numbers and reports. Norwood Labs, as one example, publishes reports for named samples on its lab results page and is explicit that they document the samples named in them. Other suppliers take other approaches; what matters is that the claim and the evidence line up.
5. Storage: does the supplier say how the material should be kept?
Both compounds are small organic molecules that degrade with heat, light and, in solution, time. A supplier who understands the material will state storage conditions on the product page or label: cool, dark, sealed, and for solutions a sensible shelf life rather than "indefinite". The absence of any storage guidance is a soft signal that the supplier is a reseller rather than someone handling the material. For what the stability data does and does not show, see How to store RU58841.
6. Shipping: where does the parcel start, and who carries the customs risk?
Origin decides a lot. A parcel dispatched from inside the UK to a UK address, or from a supplier that collects EU VAT at checkout to an EU address, moves as ordinary domestic or duty-paid post. A parcel from outside the destination's customs area, often from Asia or North America, faces import VAT, possible handling fees, longer transit and the risk of inspection or return. None of that is about the chemistry, but it changes the effective price and the chance the order arrives. Check the stated shipping origin, the carrier, and whether tracking is provided before comparing headline prices.
7. Legal status: is the supplier framing the product honestly?
Neither compound is a controlled substance in the UK or in the EU member states we are aware of, and neither is a licensed medicine anywhere. The lawful way to sell them is as reference materials for research, with no claims about use in people. A supplier whose product pages describe results, routines or outcomes is making medicinal claims about an unlicensed product, which is a legal problem for them and a credibility problem for you: if they are loose about that, ask what else they are loose about. Our UK position is laid out in Is RU58841 legal in the UK?, and the EU picture in RU58841 and pyrilutamide in the EU.
What does a report not tell you?
Three things, and they are worth stating plainly. It does not tell you anything about safety or effect in people; analytical chemistry measures content, nothing else. It does not tell you about units other than the one sampled, unless batch tracing is in place. And it does not tell you the material was handled well after testing: a verified 99% powder stored in a hot warehouse for a year is not the sample the lab saw. A report is the start of due diligence, not the end of it.
A one-minute version of the checklist
Identity method named. Assay or purity result against label. Lab named and report ID verifiable. Batch number on the label that matches a published report, or an honest statement that reports are for named samples. Storage guidance stated. Shipping origin and VAT handling stated. Research-use framing with no claims about people. A supplier that meets all seven is verifiable. A supplier that meets none is asking for trust it has not earned.